World Health Organization Warns: Falsified Diabetes Medications Circulating
Global Health Authority (GHA) issues alert for phony Diabetes drugs that have been circulating since 2022, affecting every corner of the globe. Particular instances were mentioned in the UK, the US, and Brazil, starting from October 2023, according to the GHA.
The fake drugs in question are Ozempic, a medication containing Semaglutide, an active component that's also approved in the EU for managing Type 2 Diabetes. The counterfeit version is indistinguishable from the authentic one, as it also reduces appetite, leading to its growing prescription for weight loss purposes.
The risks associated with these counterfeit drugs include improper amounts of active ingredients, potentially causing unregulated blood sugar levels in Diabetics, and potentially hazardous substances that could negatively affect health, as stated by the GHA.
The GHA advises medical professionals, pharmacists, regulatory bodies, and the general public to exercise caution. Prescriptions should be the only means of obtaining medications from pharmacies, not online sources, according to the GHA. Users should check the dosage scale on insulin pens for accuracy, verify the label, and ensure there are no spelling mistakes on the packaging.
Read also:
The World Health Organization (WHO) strongly urgges medical professionals to be vigilant when prescribing Diabetes medication, as counterfeit versions of Ozempic, containing Semaglutide, have been circulating globally since 2022. The WHO calls on regulatory bodies to emphasize the importance of obtaining medications through prescriptions only, rather than online sources, to combat this issue. Additionally, the WHO advises patients to verify the label and dosage scale on insulin pens for accuracy, ensuring there are no spelling mistakes on the packaging to avoid unintended health consequences.
